Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Banks

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
JCO Precision Oncology|September 11, 2020
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim AnalysisSeung Tae Kim, Kimberly C Banks, Se-Hoon Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC StudyHan Si, Michael Kuziora, Katie J Quinn, et al.
Royal Society Open Science|September 19, 2018
Data availability, reusability, and analytic reproducibility: evaluating the impact of a mandatory open data policy at the journal Tom E Hardwicke, Maya B Mathur, Kyle MacDonald, et al.
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
Journal of the National Cancer Institute|May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal CancerJonathan M Loree, Ann M Bailey, Amber M Johnson, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
BMC Evolutionary Biology|June 23, 2011
"Nested" cryptic diversity in a widespread marine ecosystem engineer: a challenge for detecting biological invasionsPeter R Teske, Marc Rius, Christopher D McQuaid, et al.
General and Comparative Endocrinology|June 1, 2011
Environmental influences on Adelie penguin breeding schedules, endocrinology, and chick survivalC E Ninnes, J R Waas, N Ling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
CNS Oncology|March 12, 2019
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumorsDavid E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
JCO Precision Oncology|September 11, 2020
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim AnalysisSeung Tae Kim, Kimberly C Banks, Se-Hoon Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC StudyHan Si, Michael Kuziora, Katie J Quinn, et al.
Royal Society Open Science|September 19, 2018
Data availability, reusability, and analytic reproducibility: evaluating the impact of a mandatory open data policy at the journal Tom E Hardwicke, Maya B Mathur, Kyle MacDonald, et al.
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
Journal of the National Cancer Institute|May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal CancerJonathan M Loree, Ann M Bailey, Amber M Johnson, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
BMC Evolutionary Biology|June 23, 2011
"Nested" cryptic diversity in a widespread marine ecosystem engineer: a challenge for detecting biological invasionsPeter R Teske, Marc Rius, Christopher D McQuaid, et al.
General and Comparative Endocrinology|June 1, 2011
Environmental influences on Adelie penguin breeding schedules, endocrinology, and chick survivalC E Ninnes, J R Waas, N Ling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
CNS Oncology|March 12, 2019
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumorsDavid E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, et al.
Pageof 37